Participants 207 262 6
adults with smear-positive pulmonary tuberculosis (TB),
Participants 308 459 4
trials enrolled human immunodeficiency virus (HIV) infected participants who were not receiving antiretroviral therapy (ART) at TB treatment initiation
Participants 695 793 8
Of 750 participants who received at least one dose of study treatment, 123 (16%) were HIV-infected
Participants 1029 1055 3
HIV-infected participants,
Participants 1195 1220 3
HIV-infected participants
Participants 1374 1394 3
HIV-infected persons
Participants 1558 1578 3
HIV-infected persons
